Effect of Coffee Drink Containing Mannooligosaccharides on Total Amount of Excreted Fat in Healthy Adults
A liquid coffee drink containing mannooligosaccharides from coffee mannan (MOS) was administered to a group of healthy adults. Subsequently, the amount of fat excreted from the body was examined. The subjects were divided into two groups: One was administered a liquid coffee drink containing MOS 3.0...
Saved in:
| Published in | Journal of Health Science Vol. 52; no. 4; pp. 482 - 485 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Tokyo
The Pharmaceutical Society of Japan
2006
Pharmaceutical Society of Japan Pharmaceutical Society of Japan, Nihon Yakugakkai |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | A liquid coffee drink containing mannooligosaccharides from coffee mannan (MOS) was administered to a group of healthy adults. Subsequently, the amount of fat excreted from the body was examined. The subjects were divided into two groups: One was administered a liquid coffee drink containing MOS 3.0 g/day whereas the other was administered a placebo drink for seven days. Both groups were fed the standardized meals during the experiment. In the amount of average excreted fat, the drink containing MOS intake showed a significant increase in comparison with the before intake group and placebo intake group (p < 0.05 and p < 0.001, respectively). In addition, fat utilization in MOS intake group was significantly lower than the before intake group and the placebo group (p < 0.05 and p < 0.001, respectively). These results suggested that the intake of MOS 3.0 g/day increased in the amount of excreted fat and decreased in fat utilization. |
|---|---|
| AbstractList | A liquid coffee drink containing mannooligosaccharides from coffee mannan (MOS) was administered to a group of healthy adults. Subsequently, the amount of fat excreted from the body was examined. The subjects were divided into two groups: One was administered a liquid coffee drink containing MOS 3.0 g/day whereas the other was administered a placebo drink for seven days. Both groups were fed the standardized meals during the experiment. In the amount of average excreted fat, the drink containing MOS intake showed a significant increase in comparison with the before intake group and placebo intake group (p < 0.05 and p < 0.001, respectively). In addition, fat utilization in MOS intake group was significantly lower than the before intake group and the placebo group (p < 0.05 and p < 0.001, respectively). These results suggested that the intake of MOS 3.0 g/day increased in the amount of excreted fat and decreased in fat utilization. A liquid coffee drink containing mannooligosaccharides from coffee mannan (MOS) was administered to a group of healthy adults. Subsequently, the amount of fat excreted from the body was examined. The subjects were divided into two groups: One was administered a liquid coffee drink containing MOS 3.0 g/day whereas the other was administered a placebo drink for seven days. Both groups were fed the standardized meals during the experiment. In the amount of average excreted fat, the drink containing MOS intake showed a significant increase in comparison with the before intake group and placebo intake group (p < 0.05 and p < 0.001, respectively). In addition, fat utilization in MOS intake group was significantly lower than the before intake group and the placebo group (p < 0.05 and p < 0.001, respectively). These results suggested that the intake of MOS 3.0 g/day increased in the amount of excreted fat and decreased in fat utilization. [INTRODUCTION] Intensive studies are underway with regard to mannooligosaccharides from coffee mannan (MOS) in an effort to reveal new functionality including the lowering of the body fat level. In somewhat obese adults, a liquid coffee drink containing MOS 3.0 g/day intake reduced the areas of subcutaneous and visceral fat. 1,2) Attempting to study this mechanism, we focused on the increase in the amount of fat excreted from the body. The rats given the food containing MOS had a higher amount of fecal fat as compared to their counterparts given a regular diet. 3) The preceding experiment by the authors reported that MOS 1.0 g/day intake was increased the concentration of excreted fat in healthy adults. 4) This result suggested that MOS intake was not only increasing the amount of total excreted fat but also inhibiting fat utilization in body. However, in order to investigate these, more accurately the clinical testing under controlled diet is required. In this study, the coffee drink containing MOS 3.0 g/day was administered to the subjects whose fecal sample was analyzed relative to the amount of fat. Furthermore, the fat utilization was examined by giving the standardized meals to all of the subjects throughout the experiment, thus standardizing the fat intake from food. |
| Author | Asakawa, Atsushi Kumao, Toshio Takehara, Isao Fujii, Shigeyoshi Fukuhara, Ikuo |
| Author_xml | – sequence: 1 fullname: Kumao, Toshio organization: Research and Development, Ajinomoto General Foods, Inc – sequence: 2 fullname: Fujii, Shigeyoshi organization: Research and Development, Ajinomoto General Foods, Inc – sequence: 3 fullname: Asakawa, Atsushi organization: Research and Development, Ajinomoto General Foods, Inc – sequence: 4 fullname: Takehara, Isao organization: New Drug Development Research Center, Inc – sequence: 5 fullname: Fukuhara, Ikuo organization: Fukuhara Clinic |
| BookMark | eNptkU9vEzEQxVeoSLSFC5_AEhIHpA3jP5vdPaEopC1SEZdytpzZ2cTBsYvtSPTb4-1CkSoOHo_l33sePV9UZz54qqq3HBZcqO7jYZ8WjVioTryozrlUbd0IaM8ee1X3LYhX1UVKBwDRQ8fPK7sZR8LMwsjWobTEPkfrf5SDz8Z663fsq_E-BGd3IRnEvYl2oMSCZ3chG8dWx3DyjwabXxgp08CuTGbWsxsyLu8f2Go4uZxeVy9H4xK9-bNfVt-vNnfrm_r22_WX9eq2xiXvcm06JLmVQg4DKIkwYs8bRDHIXuAWu2VP0ONIvQFJYAbotuNyAkih5HKUl9X72fc-hp8nSlkfbUJyzngKp6R5X5xAdQV89ww8hFP0ZTbNlZKqb7jsC_VhpjCGlCKN-j7ao4kPmoOeMtclc90IXTIvMDyD0WaTbQkzGuv-L7meJUcaLBoXvLOe_o2Cqd1POWoBsNQA5T-VBlFWUU-l4dA2IGRx-jQ7HVI2O3qa08Rs0dHTo3OZ1H9vpk_V5OVvmJG0wA |
| CitedBy_id | crossref_primary_10_1016_j_arr_2014_11_005 crossref_primary_10_1002_mnfr_201900521 crossref_primary_10_1248_bpb_b15_00662 crossref_primary_10_7717_peerj_12158 crossref_primary_10_3390_medicina54040064 crossref_primary_10_5458_bag_2_3_169 crossref_primary_10_1248_jhs_57_521 crossref_primary_10_3945_jn_110_128207 crossref_primary_10_1248_jhs_55_838 crossref_primary_10_4308_hjb_22_2_79 crossref_primary_10_1186_1476_511X_13_36 crossref_primary_10_1038_oby_2011_289 crossref_primary_10_1039_C8FO00209F crossref_primary_10_1080_10826068_2013_833108 crossref_primary_10_1038_oby_2009_308 crossref_primary_10_1016_j_ijbiomac_2013_01_025 crossref_primary_10_1016_j_procbio_2010_05_011 crossref_primary_10_5650_jos_62_997 crossref_primary_10_1016_j_bbapap_2011_08_003 |
| Cites_doi | 10.1016/S0021-9258(18)57092-7 10.11301/jsfe2000.6.133 10.1248/jhs.52.329 10.1016/0260-8774(87)90016-1 |
| ContentType | Journal Article |
| Copyright | 2006 by The Pharmaceutical Society of Japan Copyright Japan Science and Technology Agency 2006 |
| Copyright_xml | – notice: 2006 by The Pharmaceutical Society of Japan – notice: Copyright Japan Science and Technology Agency 2006 |
| CorporateAuthor | Ajinomoto General Foods aResearch and Development cFukuhara Clinic bNew Drug Development Research Center Inc |
| CorporateAuthor_xml | – name: bNew Drug Development Research Center – name: Inc – name: cFukuhara Clinic – name: aResearch and Development – name: Ajinomoto General Foods |
| DBID | AAYXX CITATION 7U7 C1K |
| DOI | 10.1248/jhs.52.482 |
| DatabaseName | CrossRef Toxicology Abstracts Environmental Sciences and Pollution Management |
| DatabaseTitle | CrossRef Toxicology Abstracts Environmental Sciences and Pollution Management |
| DatabaseTitleList | Toxicology Abstracts |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 1347-5207 |
| EndPage | 485 |
| ExternalDocumentID | 3104413841 10_1248_jhs_52_482 cs7healt_2006_005204_024_0482_04851075023 article_jhs_52_4_52_4_482_article_char_en |
| GroupedDBID | --- .55 29K 2WC 53G 5GY AAUGY ADBBV AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BKOMP CS3 D-I DIK DU5 E3Z EBS EJD FRP JMI JSF JSH KQ8 MOJWN M~E OK1 P2P RJT RYR RZJ TKC TR2 W2D X7M XSB OVT AAYXX CITATION 7U7 C1K |
| ID | FETCH-LOGICAL-c618t-a8ce3b323dd043c0fc915cc2d392cbc869e09cfe9a03e0ad08bf65cc2e4c313f3 |
| ISSN | 1344-9702 |
| IngestDate | Fri Jul 11 16:39:19 EDT 2025 Thu Aug 14 00:04:40 EDT 2025 Thu Apr 24 22:53:03 EDT 2025 Tue Jul 01 01:49:03 EDT 2025 Thu Jul 10 16:10:26 EDT 2025 Thu Aug 17 20:29:33 EDT 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c618t-a8ce3b323dd043c0fc915cc2d392cbc869e09cfe9a03e0ad08bf65cc2e4c313f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/jhs/52/4/52_4_482/_article/-char/en |
| PQID | 1443495139 |
| PQPubID | 1976379 |
| PageCount | 4 |
| ParticipantIDs | proquest_miscellaneous_19392048 proquest_journals_1443495139 crossref_primary_10_1248_jhs_52_482 crossref_citationtrail_10_1248_jhs_52_482 medicalonline_journals_cs7healt_2006_005204_024_0482_04851075023 jstage_primary_article_jhs_52_4_52_4_482_article_char_en |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2006-00-00 |
| PublicationDateYYYYMMDD | 2006-01-01 |
| PublicationDate_xml | – year: 2006 text: 2006-00-00 |
| PublicationDecade | 2000 |
| PublicationPlace | Tokyo |
| PublicationPlace_xml | – name: Tokyo |
| PublicationTitle | Journal of Health Science |
| PublicationYear | 2006 |
| Publisher | The Pharmaceutical Society of Japan Pharmaceutical Society of Japan Pharmaceutical Society of Japan, Nihon Yakugakkai |
| Publisher_xml | – name: The Pharmaceutical Society of Japan – name: Pharmaceutical Society of Japan – name: Pharmaceutical Society of Japan, Nihon Yakugakkai |
| References | 1) Asano, I., Fujii, S., Ozaki, K., Takehara, I., Yano, Y. and Fukuhara, I. (2005) Effects of ''Coffee Beverage'' containing mannooligosaccharides from coffee on human abdominal fat by long term ingestion. Jap. J. Food Engineering, 6, 133-141. 2) Asano, I., Fujii, S., Kaneko, M., Takehara, I. and Fukuhara, I. (2006) Investigation of mannooligosaccharides blended coffee beverage on abdominal fat reduction in humans. Jap. J. Med. Pharm. Sci., 55, 93-103. 3) Kumao, T., Fujii, S., Ozaki, K. and Takao, I. (2005) Effects of diets containing mannooligosaccharides from coffee mannan on fat in blood serum and liver fat in (ZUC)-fa/fa rats. Jap. J. Med. Pharm. Sci., 54, 505-509. 7) Kondo, T. and Nakae, Y. (1997) Fat examination in feces. Kensa to Gizyutsu, 25, 435-440. 8) Kumao, T., Fujii, S., Ozaki, K. and Takao, I. (2005) Effects of diets with mannooligosaccharides from coffee mannan on fat in blood serum in healthy volunteers. Jap. J. Food Engineering, 6, 301-304. 4) Kumao, T. and Fujii, S. (2006) Mannooligosaccharides blended coffee beverage intake increases the fat level in feces. J. Health Sci., 52, 329-332. 5) van de Kamer, J. H., Ten Bokkel Huinink, H. and Weyers, H. A. (1949) Rapid method for the determination of fat in feces. J. Biol. Chem., 177, 347-355. 6) Ishiguro, H. and Kondo, T. (2004) Measurement of fecal fat. Nippon Rinsho, 62(Suppl.), 196-199. Asano, I., Fujii, S., Ozaki, K., Ta (1) 2005; 6 Asano, I., Fujii, S., Kaneko, M., T (2) 2006; 55 Kumao, T., Fujii, S., Ozaki, K. and (3) 2005; 54 4 Kondo, T. and Nakae, Y. (7) 1997; 25 Ishiguro, H. and Kondo, T. (6) 2004; 62 8 van de Kamer, J. H., Ten Bokkel Hui (5) 1949; 177 |
| References_xml | – reference: 3) Kumao, T., Fujii, S., Ozaki, K. and Takao, I. (2005) Effects of diets containing mannooligosaccharides from coffee mannan on fat in blood serum and liver fat in (ZUC)-fa/fa rats. Jap. J. Med. Pharm. Sci., 54, 505-509. – reference: 4) Kumao, T. and Fujii, S. (2006) Mannooligosaccharides blended coffee beverage intake increases the fat level in feces. J. Health Sci., 52, 329-332. – reference: 2) Asano, I., Fujii, S., Kaneko, M., Takehara, I. and Fukuhara, I. (2006) Investigation of mannooligosaccharides blended coffee beverage on abdominal fat reduction in humans. Jap. J. Med. Pharm. Sci., 55, 93-103. – reference: 8) Kumao, T., Fujii, S., Ozaki, K. and Takao, I. (2005) Effects of diets with mannooligosaccharides from coffee mannan on fat in blood serum in healthy volunteers. Jap. J. Food Engineering, 6, 301-304. – reference: 7) Kondo, T. and Nakae, Y. (1997) Fat examination in feces. Kensa to Gizyutsu, 25, 435-440. – reference: 5) van de Kamer, J. H., Ten Bokkel Huinink, H. and Weyers, H. A. (1949) Rapid method for the determination of fat in feces. J. Biol. Chem., 177, 347-355. – reference: 1) Asano, I., Fujii, S., Ozaki, K., Takehara, I., Yano, Y. and Fukuhara, I. (2005) Effects of ''Coffee Beverage'' containing mannooligosaccharides from coffee on human abdominal fat by long term ingestion. Jap. J. Food Engineering, 6, 133-141. – reference: 6) Ishiguro, H. and Kondo, T. (2004) Measurement of fecal fat. Nippon Rinsho, 62(Suppl.), 196-199. – volume: 55 start-page: 93 issn: 0015-749X year: 2006 ident: 2 publication-title: Jap. J. Med. Pharm. Sci. – volume: 25 start-page: 435 year: 1997 ident: 7 publication-title: Kensa to Gizyutsu – volume: 177 start-page: 347 issn: 0021-9258 year: 1949 ident: 5 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)57092-7 – volume: 6 start-page: 133 issn: 0260-8774 year: 2005 ident: 1 publication-title: Jap. J. Food Engineering doi: 10.11301/jsfe2000.6.133 – volume: 54 start-page: 505 issn: 0015-749X year: 2005 ident: 3 publication-title: Jap. J. Med. Pharm. Sci. – ident: 4 doi: 10.1248/jhs.52.329 – ident: 8 doi: 10.1016/0260-8774(87)90016-1 – volume: 62< start-page: 196 issn: 0047-1852 year: 2004 ident: 6 publication-title: Nippon Rinsho |
| SSID | ssj0029081 ssib001535538 ssib023157150 ssib017172190 |
| Score | 1.715656 |
| Snippet | A liquid coffee drink containing mannooligosaccharides from coffee mannan (MOS) was administered to a group of healthy adults. Subsequently, the amount of fat... |
| SourceID | proquest crossref medicalonline jstage |
| SourceType | Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 482 |
| SubjectTerms | coffee excreted fat fat utilization mannooligosaccharide |
| Title | Effect of Coffee Drink Containing Mannooligosaccharides on Total Amount of Excreted Fat in Healthy Adults |
| URI | https://www.jstage.jst.go.jp/article/jhs/52/4/52_4_482/_article/-char/en http://mol.medicalonline.jp/en/journal/download?GoodsID=cs7healt/2006/005204/024&name=0482-0485e https://www.proquest.com/docview/1443495139 https://www.proquest.com/docview/19392048 |
| Volume | 52 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Journal of Health Science, 2006, Vol.52(4), pp.482-485 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZg4YC0QjxFYQFLcEFVihM7rxsVbLWCZRFSKvUWOY4DaXcTtEkF5dczE6dJoy3icbGiZOK0ns_2eJ6EvLQTGbDAVzjTuCX8xLNCkWkrELafgPgf-o0F_-OZdzIX7xfuondib6JL6mSifu6NK_kfrsI94CtGyf4DZ7tO4QZcA3-hBQ5D-1c8blMPo0dFCZd6_O4SjpYYxVebwg_o3VKU5Xn-paykwgirPNWNgSAqMQpyeoGlIhrvwh8gPqL0OZNN0QATnrQZTzE_R_UbEdYEUY63oUEgrEblamNsObAJFztqBnTlLgdO2bP1Ms8HytdpJVfyuxxoWCO50phTulfwdiqKnfWUC2GFPhssuK6zAyyxs3oKU4eo3YiFqeVzZY13BMYtLL9WE9eZdK_sJtI--xTP5qencXS8iK6TGw6cILC4xYfPnYHJCVlgzuLt72sz10Lfr_ueB7LKzSWI65iH4fDCmNBMKpMre3gjmER3yO2WHXRq4HGXXNPFPXJo1LHUsPE-yQ1UaJlRAxXaQIX2UKF7oULLgjZQoQYq2MEWKhSgQvOi_caGGqg8IPPZcfT2xGqrbFjKs4PakoHSPOEOT1MmuGKZCm1XKScFyVklKvBCzUKV6VAyrplMWZBkHhJoobjNM_6QHBRloR8RqkViS6Y9P0x9kWU8cYUWXDvSS-ErAR-RV9vxjFWbgh4roZzHeBSFsY9h7GPXiWHsR-RFR_vNJF7ZSxUYtnQ07WTsaEwDpN0THEFYPUbkzYCRcTuxq1hVfjN_sEQrOn26DhMxyLIxw26ggX0MBG0H_s_Rlvf927YQXMC5hYcj8rx7DIs2WuJkocs10IQwuNDR4z9SPCG3eqXfETmoL9f6KYjBdfKsAfQvw4a2Bw |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+Coffee+Drink+Containing+Mannooligosaccharides+on+Total+Amount+of+Excreted+Fat+in+Healthy+Adults&rft.jtitle=Journal+of+health+science+%28Tokyo%2C+Japan%29&rft.au=Kumao%2C+T&rft.au=Fujii%2C+S&rft.au=Asakawa%2C+A&rft.au=Takehara%2C+I&rft.date=2006&rft.issn=1344-9702&rft.volume=52&rft.issue=4&rft.spage=482&rft.epage=485&rft_id=info:doi/10.1248%2Fjhs.52.482&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1344-9702&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1344-9702&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1344-9702&client=summon |